Reconstructive Management of Peri-implantitis

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

November 15, 2022

Study Completion Date

November 16, 2022

Conditions
Resolution of Pathologic Process
Interventions
PROCEDURE

Reconstructive therapy of peri-implantitis by means of bone graft (and barrier membrane in the test group)

"A full-thickness flap was raised to ensure sufficient access. Debridement of granulation tissue was subsequently conducted using a mini-five curette (Hu-Friedy) and site-specific Gracey curettes (Hu-Friedy). The surgical approach was tailored to the clinical scenario. Specifically, resective therapy by means of implantoplasty was performed for supracrestal defects (Meisinger LLC, Nauss, Germany). Surface detoxification was performed with 3% hydrogen peroxide during 2 minutes and irrigation with 0.12% chlorhexidine. The intraosseous compartment was grafted using mineralized and demineralized bone graft (LifeNet Health, Virginia, USA). The graft was compartmentalized in the test group with a collagen porcine resorbable membrane (RTM, Cytoplast, California, USA) adapted to the defect morphology. Nylon 5.0 (Resorba Sutures, Osteogenics Biomedical, Lubbock, Texas) was used for suturing, ensuring primary wound closure"

Trial Locations (1)

06011

Clinica CICOM, Badajoz

All Listed Sponsors
lead

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

OTHER

NCT05282667 - Reconstructive Management of Peri-implantitis | Biotech Hunter | Biotech Hunter